Related Experiment Videos
Increased serum copper in primary pulmonary hypertension: a possible pathogenic link?
Respiration; International Review of Thoracic Diseases
|January 1, 1985
Summary
Elevated serum copper levels may be linked to primary pulmonary hypertension. Studies in sheep showed copper sulfate increased pulmonary vascular resistance, suggesting a potential role for copper in this condition.
Area of Science:
- Cardiovascular Research
- Trace Element Metabolism
- Pulmonary Medicine
Background:
- Pulmonary hypertension is a severe condition with complex pathophysiology.
- Copper's role in cardiovascular regulation is not fully understood.
- Previous research indicated alpha-adrenergic pathways influence pulmonary vascular resistance.
Purpose of the Study:
- To investigate the potential link between elevated serum copper and primary pulmonary hypertension.
- To explore copper's effect on pulmonary vascular resistance in an animal model.
Main Methods:
- Intravenous infusion of copper sulfate in conscious sheep.
- Assessment of pulmonary vascular resistance before and after copper infusion, with and without alpha-adrenergic blockade or catecholamine depletion.
- Measurement of serum copper levels in patients with primary pulmonary hypertension and healthy controls.
Main Results:
- Copper sulfate infusion significantly increased pulmonary vascular resistance in sheep.
- This increase was mitigated by alpha-adrenergic blockade and catecholamine depletion.
- Patients with primary pulmonary hypertension exhibited significantly higher mean serum copper levels compared to normal women.
Conclusions:
- Increased serum copper may serve as a marker or contributing factor in primary pulmonary hypertension.
- Copper's influence on the adrenergic system might play a role in pulmonary vascular resistance.
- Further research is warranted to elucidate the causal relationship between copper and pulmonary hypertension.